QUOTED. Nov. 5, 2018. Iya Khalil.
GNS Healthcare and its REFS (Reverse Engineering, Forward Simulation) AI platform is at the forefront of bringing targeted artificial intelligence solutions to biopharmaceutical companies, health plans and research organizations by helping to support better decision-making, better outcomes and cost savings. See what GNS cofounder Iya Khalil said about it here.
"Our goal is to not just predict disease. Our goal is to understand why you're getting a disease, so we know how to change it and to make recommendations as to what the best treatment is, or what the best biological new pathway to go after is." –Iya Khalil, cofounder, GNS Healthcare
- Find out more: Start-Up Spotlight: GNS Healthcare Deploys Causal Algorithms To Drive Health Outcomes, Save Costs
Click here for a free trial of Medtech Insight